Literature DB >> 16201843

Nutritional intervention with omega-3 Fatty acids in a case of malignant fibrous histiocytoma of the lungs.

Ronald S Pardini1, David Wilson, Steven Schiff, Stephen A Bajo, Randall Pierce.   

Abstract

We present a case of a 78-yr-old man with malignant fibrous histiocytoma with multiple lesions in both lungs. Following diagnosis, he declined conventional chemotherapy and elected nutritional intervention by increasing intake of omega-3 fatty acids and lowering intake of omega-6 fatty acids. We estimated that he consumed 15 g of the long-chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) per day, and the ratio of linoleic acid/long-chain omega-3 fatty acids in his diet was 0.81. Serial computed tomography scans and pulmonary x-rays revealed remarkably a slow and steady decrease in the size and number of bilateral nodules. He has no apparent side effects from consuming large quantities of fish and algae oils rich in DHA and EPA and he remains asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201843     DOI: 10.1207/s15327914nc5202_2

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  3 in total

1.  Incorporation of eicosatrienoic acid exerts mild anti-inflammatory properties in murine RAW264.7 cells.

Authors:  Szu-Jung Chen; Lu-Te Chuang; Sung-Nien Chen
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line.

Authors:  Takashi Yamagami; Christopher D Porada; Ronald S Pardini; Esmail D Zanjani; Graça Almeida-Porada
Journal:  Cancer Biol Ther       Date:  2009-02-03       Impact factor: 4.742

Review 3.  Shrimp lipids: a source of cancer chemopreventive compounds.

Authors:  Carmen-María López-Saiz; Guadalupe-Miroslava Suárez-Jiménez; Maribel Plascencia-Jatomea; Armando Burgos-Hernández
Journal:  Mar Drugs       Date:  2013-10-16       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.